GlassScriptPhysician profile
Wilmot C Burch
NPI 1700813276
$471.78
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $195 · 2023: $86.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $86.72 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.63 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.42 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $69.55 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $40.16 | 2020 | |
| Abbvie INC. | $36.16 | 2019-2020 | |
| Alfasigma USA, INC. | $27.53 | 2020 | |
| Allergan, INC. | $18.32 | 2019 | |
| Pfizer INC. | $14.47 | 2019 | |
| Ucb, INC. | $13.16 | 2019 | |
| Daiichi Sankyo INC. | $11.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilmot Burch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.